DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20171107

Monitoring of adverse drug reactions to antidepressant drugs in a teaching hospital

Swetha Munoli, Soumya B. Patil

Abstract


Background: Adverse drug reactions (ADRs) are considered among the leading causes of morbidity and mortality. Adverse drug reactions are important determinants of non-adherence to antidepressant treatment, but their assessment is complicated by overlap with depressive symptoms and lack of reliable self-report measures The present study was therefore undertaken to monitor the ADRs of the antidepressant in the psychiatric outpatient unit of Raichur Institute of Medical Sciences, Raichur, Karnataka, India

Methods: Study was conducted from December 2012 to November 2013, the   patients on antidepressant drugs from psychiatry out- patient department (OPD) of Raichur Institute of Medical Sciences were considered for analysis. The patients were diagnosed by consultant psychiatrist. Data was collected in standard questionnaire format. All patients diagnosed with psychiatric disorder as per ICD 10 criteria and receiving treatment with antidepressant were included. Assessment of causality and severity of recorded adverse events was done using WHO assessment scale and modified Siegel and Hartwig Scale respectively.

Results: In our study 74 adverse drug reactions(ADRs) were seen among 52 cases, total 263 cases were screened.CNS and Anticholinergic side effects were most common adverse drug reactions noted. Tricyclic antidepressants (TCA) and Selective serotonin reuptake inhibitors (SSRIs) were the drugs causing maximum ADRs. Assessment of causality and severity of recorded adverse events showed possible to probable and mild to moderate severity respectively.

Conclusions: CNS and Anticholinergic side effects were most common adverse drug reactions noted. Tricyclic antidepressants (TCA) were most commonly prescribed drugs followed by Selective serotonin reuptake inhibitors (SSRIs). Tricyclic antidepressants (TCA) and Selective serotonin reuptake inhibitors (SSRIs) accounted for most of ADRs (87.8%). Assessment of causality of recorded adverse events showed no certain cause and assessment of severity of recorded adverse events showed no severe cases.


Keywords


Antidepressants, Amitriptyline, Diarrhoea, Fluoxetine, Imipramine, Insomnia

Full Text:

PDF

References


Lingeswaran A, Shetty H, Lahon K, Paramel A, Sharma G. Pharmacovigilance on olanzapine. Indian J Pharmacol. 2010;42:252-3.

World Health Organization. Mental health. Fact sheet on Depression. Available from: http://www.who.int/mediacentre/factsheets/fs369/en/

Richelson E. Interaction of antidepressants with neurotransmitter transporters and receptors and their clinical relevance. J Clin Psychiatry. 2003;64:5‑12.

Lucca JM, Madhan R, Gurumurthy P, Dushad R. A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India. Indian J Pharmacol. 2014;46:543‑6.

Mishra S, Swain TR, Mohanty M. Adverse drug reaction monitoring of antidepressants in the psychiatry outpatients department of a tertiary care teaching hospital. J Clin Diagn Res. 2013;7:1131‑4.

Mukherjee S, Sen S, Chatterjee SS, Era N, Ghosal M, Tripathi SK. Adverse drug reaction monitoring of antidepressants in the psychiatry outpatient department at a tertiary care teaching hospital in India: a cross‑sectional observational study. Eur J Psychol Educ Studies. 2015;2:14-9.

Solanke B, Mahatme MS, Dakhale G, Hiware S, Shrivastava M, Waradkar P. Adverse drug reaction profile at psychiatry out‑patient department of a tertiary referral centre in Central India. Int J Basic Clin Pharmacol. 2013;2:341‑3.

Carlini EL, Nappo SA. The pharmacovigilance of psychoactive agents in Brazil. Rev Bras Psiquiatr. 2003;25:200-5.

Jose J, Rao PGM. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacologic Res. 2006;54:226-33.

Grohmann R, Hippius H, Helmchen H, Ruther E, Schmidt LG. The AMPU study for drug surveillance in psychiatry-a summary of inpatient data. Pharmacopsychiatry. 2004:37:S16-26.